EndoCellutions Inc. is committed to advancing the field of regenerative medicine by developing technologies to enable physicians to prepare and concentrate adult or neonatal (afterbirth) stem cells. Our technologies are simple and robust, are developed in consultation with experts who need such devices, and produce consistent results of comparable or better quality than available alternatives (where extant). From an initial focus on orthopedic applications of bone marrow stem cells, we intend to expand to other indications and sources of autologous stem cells. By removing or minimizing the technical hurdles associated with preparation of stem cell concentrates, research and medical professionals can focus on advancing and delivering quality, affordable regenerative care, which is poised to be the next revolution in patient treatment.